According to the latest market research study published by P&S Intelligence, the global medical exoskeleton market was valued at USD 485.8 million in 2023 and is projected to experience a remarkable CAGR of 44.8% from 2024 to 2030, reaching an estimated USD 6,336.8 million by 2030. This substantial growth is primarily driven by the increasing number of individuals with physical disabilities, a rising geriatric population, and a growing number of orthopedic surgeries. According to the World Health Organization (WHO), approximately 1.3 billion people, or one in six globally, experience significant disability.
Additionally, the market is influenced by the rising
incidence of neurological diseases, such as ataxia, Parkinson’s disease,
amyotrophic lateral sclerosis, acute spinal cord injury, and Alzheimer’s
disease. These conditions often result in the loss of control and coordination
of physical movements, thereby increasing the demand for medical exoskeletons. Furthermore,
the growing number of road accidents, severe injuries, and strokes contributes
to the market's expansion. The WHO reports that approximately 1.3 million
people die each year due to road traffic crashes, highlighting the need for
advanced rehabilitation solutions.
Download free Reports Sample Now
Key Insights
Segmentation Analysis:
· Component: In 2023, hardware components
accounted for 60% of the market share, owing to the essential role of sensors,
powered systems, actuators, and control systems in exoskeletons. The hardware
segment is expected to grow at a CAGR of 45.0% during 2024–2030. Software
components are anticipated to grow at a CAGR of 45.2% in the same period,
driven by the integration of artificial intelligence (AI) to enhance
exoskeleton functionality.
· Type: Powered exoskeletons held a larger
market share in 2023, attributed to recent technological advancements. For
instance, Stanford University, with funding from the National Institutes of
Health (NIH), developed an exoskeleton that adapts rapidly to users’ movements
during normal walking. Key industry players are focusing on integrating AI to
boost human potential and device productivity. For example, in December 2021,
German Bionic launched the fifth generation of Cray X, featuring active walking
assistance and a new energy management system.
Regional and Geographical Trends:
North America is expected to dominate the medical
exoskeleton market during the forecast period, driven by advanced healthcare
infrastructure, high adoption rates of innovative technologies, and supportive
government initiatives. Europe is projected to follow, with significant growth
anticipated in the Asia-Pacific region due to increasing healthcare investments
and a rising geriatric population.
Technological Advancements Shaping the Market:
The integration of AI and machine learning into medical
exoskeletons is enhancing their adaptability and efficiency. For example,
Blackrock Neurotech partnered with Phantom Neuro to develop the Phantom X
system, enabling patients to control assistive devices like exoskeletons and
prosthetics in real-time. Additionally, Ekso Bionics Holdings Inc. received FDA
clearance for EksoNR for rehabilitative use in multiple sclerosis patients,
expanding its application beyond stroke and spinal cord injury rehabilitation.
Competitive Dynamics, Major Players, and Emerging
Opportunities:
The medical exoskeleton market is characterized by intense
competition, with key players focusing on technological innovations and
strategic partnerships to strengthen their market positions. Emerging
opportunities include the development of lightweight, affordable exoskeletons
and expanding applications in rehabilitation centers and home care settings. Companies
are also exploring untapped markets in developing economies, aiming to cater to
the growing demand for advanced mobility solutions.
%20Market.png)